Dealmaking

Tech deal processes will kick off after Labor Day, predicts Clearlake’s Prashant Mehrotra; Disruption Matters podcast features AI tools

A Q&A with Prashant Mehrotra, partner and managing director at Clearlake Capital Group, who discussed his outlook for tech sector M&A in the second half of 2025 and how AI is expected to drive deals within the sector; the latest episode of the fourth season of the Disruption Matters podcast miniseries has dropped and features leaders at Goldman Sachs, Partners Group, AlixPartners, BayPine and Prysm Capital discussing best practices for leveraging AI to help companies grow.

Clearlake’s Prashant Mehrotra: Tale of two cities, as AI emboldens big bets from strategics while PE firms take a more measured approach

'If you unpack what's happened in PE, you've seen very episodic transactions, sometimes sponsor-to-sponsor, sometimes take-privates. But they're all largely focused on premier assets.'

Bain, PSG see EU regulatory tailwinds for Namirial-Signaturit tie-up; Less than half of UK accountants open to outside investment, survey finds

Bain and PSG entered exclusive negotiations to merge the companies in early July.

Bain Capital, PSG double down on digital sovereignty with Namirial-Signaturit merger

Bain and PSG entered exclusive talks for the merger of Namirial and Signaturit in early July.

Disruption Matters: Winning the digital race

Given volatility and the increasingly competitive landscape, growth is a necessity for any enterprise to withstand the storm. In this episode, we’ll explore how best to deploy today’s revolutionary tech to drive growth at portfolio companies.

Temasek’s 65 Equity leverages growing demand for non-control deals; Partners Group, Polaris, RF bet on pet health

A deep dive into private equity investments in the pet sector; why 65 Equity Partners, the private equity affiliate of Singapore sovereign wealth fund Temasek, believes demand for non-control mid-market deals in the US is underserved; a look at Barnes & Thornburg’s 2025 Investment Funds Outlook Report.

Animal health industry is a sweet spot for PE investors

Polaris, RF Investment Partners and Partners Group are investing in animal pharma in several areas.

Apollo’s David Sambur: ‘We have not seen the floodgates open just yet’

'What comes next requires more price discipline, a focus on operational value creation and a back-to-basics mindset for the private equity industry,' Sambur tells affiliate title PE Hub.

Burst of deals with Bridgepoint, Partners Group, Carlyle, EQT and Perwyn in action; AXA IM Prime and Mubadala in GP stakes deal

EQT has agreed to buy Adevinta’s Spanish operations from the Blackstone- and Permira-owned company.

65 Equity US co-heads: Mid-market demand for non-control options is underserved

In their first joint interview, newly appointed US co-heads Sean Murphy and Leon Brujis told Buyouts that the Temasek affiliate is poised to pick up vast opportunities in the US mid-market.